Tech Center 1600 • Art Units: 1636 1653 1656
This examiner grants 58% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19071005 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | Non-Final OA | Halozyme, Inc. |
| 19071055 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | Non-Final OA | Halozyme, Inc. |
| 18548640 | REDUCING HIGH MANNOSE GLYCAN PROTEIN EXPRESSION USING GUANOSINE 5'-MONOPHOSPHATE | Non-Final OA | MERCK SHARP & DOHME LLC |
| 18278695 | METHODS FOR GENERATING A CRISPR ARRAY | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18016428 | COMPOSITIONS AND METHODS FOR TREATING AN INHERITED RETINAL DISEASE | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17997877 | ACE2 COMPOSITIONS AND METHODS | Final Rejection | The Regents of the University of California |
| 17767844 | METHODS TO STABILIZE MAMMALIAN CELLS | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18030700 | BACILLUS CELL WITH REDUCED LIPASE AND/OR ESTERASE SIDE ACTIVITIES | Non-Final OA | BASF SE |
| 19293034 | MUTANTS OF IMMUNOGLOBULIN-DEGRADING ENZYME IDEE | Final Rejection | SHANGHAI BAO PHARMACEUTICALS CO., LTD. |
| 18021135 | CELL HAVING GENE CORRECTED EX VIVO AND USE THEREOF | Non-Final OA | IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) |
| 18015753 | SELF-ELIMINATING TRANSGENES | Non-Final OA | The Texas A&M University System |
| 17726324 | GENETICALLY MODIFIED RECOMBINANT CELL LINES | Final Rejection | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
| 18033166 | Compositions and Methods Relating to Alzheimer's Disease | Non-Final OA | Duke University |
| 17604714 | METHODS OF IMPROVING THE LONGEVITY OF IMMUNE CELLS | Non-Final OA | University of Houston System |
| 17921035 | CHIMERIC POLYPEPTIDES AND METHODS OF PREPARING SAME | Non-Final OA | RAMOT AT TEL-AVIV UNIVERSITY LTD. |
| 17620557 | PRODUCTION OF VECTORS USING PHAGE ORIGIN OF REPLICATION | Final Rejection | ASKBIO INC. |
| 18014348 | CLEANING COMPOSITIONS AND USES THEREOF | Non-Final OA | Henkel AG & Co. KGaA |
| 17786561 | CLEANING COMPOSITIONS COMPRISING DISPERSINS VIII | Final Rejection | Henkel AG & Co. KGaA |
| 17820488 | RETINAL ORGANOID MODEL SYSTEMS | Non-Final OA | Wisconsin Alumni Research Foundation |
| 16978461 | EXPRESSION OF HETEROLOGOUS ENZYMES IN YEAST FOR FLAVOURED ALCOHOLIC BEVERAGE PRODUCTION | Non-Final OA | Danstar Ferment AG |
| 17793753 | HUMAN IMMUNOGENIC EPITOPES OF HEMO AND HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVS) | Non-Final OA | The United States of America,as represented by the Secretary,Department of Health and Human Services |
| 17525433 | CELL ENGINEERING USING RNAs | Non-Final OA | Boehringer Ingelheim International GmbH |
| 17627088 | PRODUCTION OF FUCOSYLLACTOSE IN HOST CELLS | Non-Final OA | INBIOSE N.V. |
| 18283614 | REDUCING HOST CELL IMPURITIES DURING RECOMBINANT PROTEIN PRODUCTION | Non-Final OA | Biogen MA Inc. |
| 18680688 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND EXOSPORIUM FRAGMENTS FOR PLANT HEALTH | Non-Final OA | Spogen Biotech Inc. |
| 18434301 | DELIVERY OF ACTIVE AGENTS | Final Rejection | MannKind Corporation |
| 17635349 | COMPOSITIONS AND METHODS FOR INCREASED PROTEIN PRODUCTION IN BACILLUS LICHENIFORMIS | Non-Final OA | DANISCO US INC. |
| 18628548 | METHODS FOR PRODUCING BIOGAS AND RENEWABLE NATURAL GAS USING CO-PRODUCTS FROM A STILLAGE STREAM AS FEEDSTOCKS | Non-Final OA | Marquis IP LLC |
| 18444368 | COMPOSITIONS AND METHODS FOR GENE EDITING | Final Rejection | CRISPR THERAPEUTICS AG |
| 18376543 | Composition and Method of an Orally Administered Antimicrobial Peptide Vectored in a Bacterial Expression Vehicle | Non-Final OA | The United States of America as represented by the Secretary of Agriculture |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy